ABIONYX Pharma SA's market cap is currently €126.12M. The company's EPS TTM is €-0.066; its P/E ratio is ―; ABIONYX Pharma SA is scheduled to report earnings on September 25, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
